Associations - LYN mutation

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

LYN mutation	Non Small Cell Lung Cancer	LYN mutation	Non Small Cell Lung Cancer	nivolumab + ipilimumab Sensitive: C3 – Early Trials nivolumab + ipilimumab Sensitive : C3	nivolumab + ipilimumab Sensitive: C3 – Early Trials nivolumab + ipilimumab Sensitive : C3
LYN mutation	Melanoma	LYN mutation	Melanoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3